HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshio Matsumoto Selected Research

YM 529

7/2020Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study.
1/2020Minodronate.
9/2013Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial.
7/2012Three years of treatment with minodronate in patients with postmenopausal osteoporosis.
6/2009A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshio Matsumoto Research Topics

Disease

44Osteoporosis
01/2021 - 12/2002
25Multiple Myeloma
01/2021 - 09/2002
23Neoplasms (Cancer)
01/2021 - 06/2003
22Bone Resorption
01/2022 - 09/2002
14Atherosclerosis
01/2020 - 09/2002
8Hypocalcemia
07/2019 - 12/2003
7Osteomalacia
01/2020 - 10/2007
7Rickets (Rachitis)
01/2020 - 12/2003
7Carotid Artery Diseases
04/2016 - 06/2004
6Inflammation (Inflammations)
01/2022 - 08/2002
6Osteoporotic Fractures
05/2021 - 10/2011
6Hypoparathyroidism
07/2019 - 04/2007
6Fibrosis (Cirrhosis)
01/2018 - 08/2005
6Wrist Fractures
10/2014 - 10/2011
6Muscular Diseases (Myopathy)
07/2004 - 08/2002
5Hypercalcemia (Milk Alkali Syndrome)
11/2019 - 09/2005
5Ischemia
01/2018 - 01/2005
5Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 10/2009
5Insulin Resistance
12/2017 - 04/2004
5Hypertension (High Blood Pressure)
01/2014 - 01/2003
5Vascular Remodeling
01/2011 - 02/2004
5Mitochondrial Diseases (Mitochondrial Disease)
07/2004 - 02/2002
4Diabetes Mellitus
12/2021 - 06/2004
4Metabolic Bone Diseases (Osteopenia)
12/2020 - 01/2008
4Hypertrophy
04/2010 - 11/2003
3Urolithiasis
01/2022 - 12/2012
3Body Weight (Weight, Body)
09/2021 - 02/2010
3Breast Neoplasms (Breast Cancer)
12/2018 - 12/2002
3Hypercalciuria
01/2016 - 04/2015
3Coronary Artery Disease (Coronary Atherosclerosis)
08/2015 - 09/2002
3Postmenopausal Osteoporosis
07/2012 - 01/2008
3Heart Failure
01/2012 - 10/2009
3Lymphoma (Lymphomas)
08/2010 - 12/2004
3Disease Progression
01/2010 - 06/2003
3Ophthalmoplegia (External Ophthalmoplegia)
12/2005 - 09/2002
2Rheumatoid Arthritis
01/2022 - 08/2014
2Albuminuria
12/2021 - 06/2011

Drug/Important Bio-Agent (IBA)

16Diphosphonates (Bisphosphonates)IBA
01/2022 - 05/2002
13Vitamin DFDA LinkGeneric
11/2020 - 06/2003
13eldecalcitol (ED 71)IBA
07/2020 - 09/2005
12Biomarkers (Surrogate Marker)IBA
12/2021 - 07/2004
12alfacalcidolIBA
07/2020 - 07/2010
11MineralsIBA
12/2020 - 11/2004
7CalciumIBA
01/2022 - 09/2006
7Collagen Type I (Type I Collagen)IBA
01/2022 - 01/2007
7Heparin Cofactor IIIBA
12/2021 - 02/2004
7ThrombinFDA Link
12/2021 - 02/2004
7Phosphates (Orthophosphate)IBA
09/2021 - 10/2007
7DenosumabFDA Link
01/2021 - 07/2014
7Monoclonal AntibodiesIBA
02/2015 - 02/2006
6GlucocorticoidsIBA
01/2021 - 01/2003
6Pharmaceutical PreparationsIBA
01/2021 - 01/2011
6hydroxide ionIBA
11/2020 - 12/2004
6Parathyroid Hormone (Parathormone)IBA
07/2019 - 09/2006
6Glucose (Dextrose)FDA LinkGeneric
12/2017 - 09/2003
6Adrenal Cortex Hormones (Corticosteroids)IBA
01/2011 - 08/2002
6AntibodiesIBA
01/2010 - 12/2003
6AntigensIBA
06/2009 - 11/2005
5YM 529IBA
07/2020 - 06/2009
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018 - 01/2008
5Androgen Receptors (Androgen Receptor)IBA
07/2013 - 11/2003
5AndrogensIBA
07/2013 - 08/2005
5Bortezomib (Velcade)FDA Link
06/2011 - 02/2007
4romosozumabIBA
05/2021 - 01/2017
4pitavastatin (itavastatin)FDA Link
01/2018 - 01/2008
4Cholecalciferol (Vitamin D3)FDA Link
11/2015 - 10/2011
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2013 - 12/2002
4Bone Marrow Stromal Antigen 2IBA
10/2010 - 12/2008
4Angiotensin IIIBA
04/2010 - 08/2005
4Transforming Growth Factor beta (TGF-beta)IBA
03/2010 - 01/2008
4Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
04/2008 - 09/2002
3Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2022 - 06/2009
3Peptides (Polypeptides)IBA
01/2022 - 11/2005
3AlbuminsIBA
12/2021 - 02/2010
3RANK LigandIBA
01/2021 - 04/2006
3Reactive Oxygen Species (Oxygen Radicals)IBA
04/2020 - 10/2003
3LigandsIBA
04/2020 - 01/2012
3Calcium-Sensing ReceptorsIBA
07/2019 - 01/2013
3Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2018 - 04/2010
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2017 - 06/2004
325-hydroxyvitamin DIBA
01/2017 - 10/2014
3Anabolic AgentsIBA
10/2015 - 01/2008
3Teriparatide (Parathar)FDA Link
10/2014 - 01/2008
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2013 - 09/2005
3Dexamethasone (Maxidex)FDA LinkGeneric
06/2013 - 08/2007
3Adenosine Triphosphate (ATP)IBA
02/2012 - 04/2004
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2010 - 06/2003
3GangliosidesIBA
01/2010 - 06/2003
3Chemokine CCL4IBA
04/2008 - 09/2002
3Alkaline PhosphataseIBA
01/2008 - 10/2004
2Uric Acid (Urate)IBA
01/2022 - 04/2020
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2010
2CreatinineIBA
12/2021 - 06/2011
2Glycoproteins (Glycoprotein)IBA
05/2021 - 11/2011

Therapy/Procedure

26Therapeutics
01/2021 - 09/2002
4Transplantation
01/2012 - 10/2004
3Bed Rest (Bedrest)
07/2013 - 11/2004
3Immunotherapy
07/2011 - 01/2009
3Percutaneous Coronary Intervention
12/2010 - 02/2004
3Stents
10/2009 - 07/2003